Cravath Publishes Winter 2026 Issue of Alumni Journal
Cravath represented the underwriters, led by Barclays and Citigroup, in connection with the $386 million registered common stock offering of Sabra Health Care REIT, Inc., a self‑administered, self‑managed REIT that owns and invests in real estate serving the health care industry. The shares were listed on the NASDAQ Global Select Market. The transaction closed on September 28, 2017.
The Cravath team included partner Bill Whelan and associates Jessie Chiang and Michael Zhang on securities matters, and associate Cecily Xi on tax matters. Vardhman Shankar also worked on securities matters.
Deals & Cases
April 28, 2026
Cravath represented the initial purchasers in connection with the $3 billion 144A/Reg. S notes offering of ERAC USA Finance LLC, guaranteed by Enterprise Holdings, Inc., a leading global mobility solutions provider operating under the Enterprise Mobility corporate brand. The transaction closed on April 14, 2026.
Deals & Cases
March 26, 2026
Cravath represented the initial purchasers in connection with the $700 million 144A/Reg. S high‑yield senior notes offering of The Chemours Company a leading, global provider of performance chemicals. The transaction closed on March 12, 2026.
Deals & Cases
March 11, 2026
Cravath represented the underwriters in connection with the $600 million registered senior notes offering of Concentrix Corporation, a leading global provider of customer experience solutions and technology. The transaction closed on February 24, 2026.
Deals & Cases
March 04, 2026
Cravath represented the underwriters in connection with the $500 million registered senior notes offering of Loews Corporation, a holding company. The transaction closed on February 18, 2026.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.